---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-043244"
form_type: "8-K"
ticker: "BNGO"
cik: "0001411690"
company_name: "Bionano Genomics, Inc."
filed_at: "2024-10-10T23:59:59+00:00"
generated_at: "2026-05-30T16:30:46.146947+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Bionano lowers Q3 revenue guidance to $6.5-6.8M from $7.9-8.9M; cash $23.3M

## Summary
- Preliminary Q3 revenue $6.5-6.8M, down from prior guidance of $7.9-8.9M.
- Cash and restricted cash ~$23.3M as of Sep 30; $11.4M restricted.
- Revenue miss driven by strategic shift away from new OGM system placements and sector headwinds.
- Potential material impairments and charges pending completion of end-of-period review.

## SEC filing metadata
- accession: 0001140361-24-043244
- form_type: 8-K
- ticker: BNGO
- cik: 0001411690
- company_name: Bionano Genomics, Inc.
- filed_at: 2024-10-10T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1411690/000114036124043244/0001140361-24-043244-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1411690/000114036124043244/ef20037106_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-043244
- JSON: https://secwatch.observer/filing/0001140361-24-043244.json
- Plain text: https://secwatch.observer/filing/0001140361-24-043244.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.